We want to unravel how mutations in the KEOPS complex are involved in Galloway-Mowat syndrome, a rare autosomal recessive neurodegenerative disorder. We will make use of in vitro and in vivo model systems to untangle which pathways are affected and whether the localisation and/or expression pattern of the units of the KEOPS complex is altered by the specific mutations.